The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood ...
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback